The CorVista® System is s non-invasive medical device system, consisting of both hardware and software components, empowers physicians with a powerful tool for diagnosing significant coronary artery disease (CAD) at the point of care.
The CorVista System is designed for the evaluation of physiological signals collected from patients who are experiencing cardiovascular symptoms, including chest pain, dyspnoea, and fatigue. Its primary purpose is to provide an assessment of the probability of significant coronary artery disease.
This analysis is intended to be used by healthcare professionals in collaboration with their clinical expertise, taking into account the patient's specific signs, symptoms, and medical history. It serves as a valuable diagnostic tool to assist in reaching an accurate diagnosis.
This cutting-edge point-of-care, non-invasive solution boasts an impressive 99 percent negative predictive value (NPV) for ruling out significant coronary artery disease (CAD). It is a game-changer, eliminating the need for fasting or exposure to radiation, and it comes with minimal capital investment. With results available in just minutes, it empowers physicians to swiftly and accurately detect the potential presence of cardiac disease.
CorVista Health's innovative solution has the potential to significantly improve healthcare system and enable more equitable care.